Neogen Corporation Loss Contingency, Estimate of Possible Loss
Neogen Corporation (NEOG) had Loss Contingency, Estimate of Possible Loss of $1.90 million as of 2026-02-28, per its 10-Q filed 2026-04-09.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2026-04-09
- 2026-02-28: Loss Contingency, Estimate of Possible Loss $1.90M.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2026-02-28 | $1.90M 10-Q · filed 2026-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |